Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.37 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HTR2C | P28335 | 6/20 | 0.32 |
| ▸ | HTR3A | P46098 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.32 |
| ▸ | PLG | P00747 | 2/20 | 0.32 |
| ▸ | QDPR | P09417 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27752202 | 0.86 | KDM1A (0.44) | HRH4SLC18A3SIGMAR1MAPTHTR2C | |
| SCHEMBL828613 | 0.82 | HRH4 (0.34) | HRH4SLC18A3SIGMAR1MAPTHTR3A | |
| SCHEMBL13772777 | 0.79 | SIGMAR1 (0.39) | SLC18A3SIGMAR1MAPTHTR2CTHRB | |
| SCHEMBL121088 | 0.78 | — | — | |
| SCHEMBL6856181 | 0.78 | — | — | |
| SCHEMBL10934615 | 0.78 | — | — | |
| SCHEMBL80431 | 0.76 | KDM1A (0.45) | MAPT | |
| Cyclohexane SCHEMBL961578 | 0.76 | MAPT (0.41) | MAPT | |
| SCHEMBL6083553 | 0.76 | HTR3A (0.44) | HTR2CHTR3A | |
| Methoxymethane SCHEMBL3899156 | 0.76 | HTR2C (0.34) | HRH4HTR2CHTR3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2655497-A1 | THERMOPLASTIC MOLDING COMPOSITION | BASF SE (DE) | 2013-10-30 | — | — | EP | disclosed |
| EP-2488210-A2 | METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING OLIGONUCLEOTIDE BASED DRUGS ADMINISTERED IN VIVO OR IN VITRO | Smith Holdings, LLC (US) | 2012-08-22 | — | — | EP | disclosed |
| WO-2012084777-A1 | THERMOPLASTIC MOLDING COMPOSITION | BASF SE (DE) | 2012-06-28 | — | — | WO | disclosed |
| WO-2011046983-A2 | METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING OLIGONUCLEOTIDE BASED DRUGS ADMINISTERED IN VIVO OR IN VITRO | SMITH HOLDINGS, LLC (US) | 2011-04-21 | — | — | WO | disclosed |
| EP-1934206-A1 | PHENYL- AND PYRIDYL-I, 2 , 4 -OXADIAZOLONE DERIVATIVES WITH PHENYL GROUP, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | Sanofi-Aventis (FR) | 2008-06-25 | — | — | EP | disclosed |
| WO-2007039172-A1 | PHENYL- AND PYRIDYL-I, 2 , 4 -OXADIAZOLONE DERIVATIVES WITH PHENYL GROUP, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI-AVENTIS (DE) | 2007-04-12 | — | — | WO | disclosed |
| EP-1117652-A1 | TAN-1057 DERIVATIVES | Bayer Aktiengesellschaft (DE) | 2001-07-25 | — | — | EP | disclosed |
| WO-2000012484-A1 | TAN-1057 DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-03-09 | — | — | WO | disclosed |